261 related articles for article (PubMed ID: 24100543)
1. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.
Ma W; Shi X; Lu S; Wu L; Wang Y
Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543
[TBL] [Abstract][Full Text] [Related]
2. Embryo-chondrocyte expressed gene 1, downregulating hypoxia-inducible factor 1alpha, is another marker of lung tumor hypoxia.
Zhang L; Li QQ
Acta Pharmacol Sin; 2007 Apr; 28(4):549-58. PubMed ID: 17376295
[TBL] [Abstract][Full Text] [Related]
3. The increased expression of DEC1 gene is related to HIF-1α protein in gastric cancer cell lines.
Zheng Y; Shi X; Wang M; Jia Y; Li B; Zhang Y; Liu Q; Wang Y
Mol Biol Rep; 2012 Apr; 39(4):4229-36. PubMed ID: 21779800
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
[TBL] [Abstract][Full Text] [Related]
5. Differentiated embryo chondrocyte 1, induced by hypoxia-inducible factor 1α, promotes cell migration in oral squamous cell carcinoma cell lines.
Yang L; Zeng L; Wang Z; Hu X; Xiong H; Zhang T; Chen W; Xia K; Su T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Feb; 133(2):199-206. PubMed ID: 34758939
[TBL] [Abstract][Full Text] [Related]
6. DEC1 promotes hypoxia-induced epithelial-mesenchymal transition (EMT) in human hepatocellular carcinoma cells.
Murakami K; Wu Y; Imaizumi T; Aoki Y; Liu Q; Yan X; Seino H; Yoshizawa T; Morohashi S; Kato Y; Kijima H
Biomed Res; 2017; 38(4):221-227. PubMed ID: 28794399
[TBL] [Abstract][Full Text] [Related]
7. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
8. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
9. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
10. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
[TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
12. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
15. UVB radiation induces expression of HIF-1alpha and VEGF through the EGFR/PI3K/DEC1 pathway.
Li Y; Bi Z; Yan B; Wan Y
Int J Mol Med; 2006 Oct; 18(4):713-9. PubMed ID: 16964427
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
[TBL] [Abstract][Full Text] [Related]
17. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
[TBL] [Abstract][Full Text] [Related]
18. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
[TBL] [Abstract][Full Text] [Related]
20. DEC1 expression in 1p-aberrant oligodendroglial neoplasms.
Preusser M; Birner P; Ambros IM; Ambros PF; Budka H; Harris AL; Hainfellner JA
Histol Histopathol; 2005 Oct; 20(4):1173-7. PubMed ID: 16136500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]